Australians at Risk: Management of Cardiovascular Risk Factors in the REACH Registry

Heart Lung and Circulation

Volumn 17, Issue 2, 2008, Pages 114-118

  Reid, Christopher ^a   Nelson, Mark R ^b   Shiel, Louise ^a   Chew, Derek ^c   Connor, Greg ^d   DeLooze, Fred ^e  

^a MONASH UNIVERSITY   (Australia)

^b UNIVERSITY OF TASMANIA   (Australia)

^c FLINDERS MEDICAL CENTRE   (Australia)

^d Cardiovascular Diagnostic Services   (Australia)

^e UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Cardiovascular risk factors; General practice; Secondary prevention

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN II ANTAGONIST; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

AGE; AGED; ARTERY DISEASE; ARTICLE; AUSTRALIA; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DEMOGRAPHY; DIABETES MELLITUS; FEMALE; HIGH RISK POPULATION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; OBESITY; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SMOKING; VASCULAR DISEASE;

AGED; ATHEROSCLEROSIS; AUSTRALIA; CARDIOVASCULAR DISEASES; COHORT STUDIES; FAMILY PRACTICE; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTENSION; MALE; OBESITY; PREVALENCE; REGISTRIES; RISK FACTORS; SMOKING; THROMBOSIS;

EID: 40749153832     PISSN: 14439506     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hlc.2007.07.009     Document Type: Article

References (15)

1. Australian Institute of Health and Welfare. Living Dangerously. Australians with multiple risk factors from cardiovascular disease. In: Bulletin No. 24, editor. AIHW Cat No AUS 57. Canberra: AIHW; 2005.
2. World Health Organisation. World Health Report. Geneva: World Health Organisation; 2002.
3. Access Economics. The shifting burden of cardiovascular disease in Australia: National Heart Foundation of Australia; 2005.
4. Fowkes F.G., Housley E., Cawood E.H., MacIntyre C.C., Ruckley C.V., and Prescott R.J. Edinburgh Artery Study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population. Int J Epidemiol 20 2 (1991) 384-392
5. Chobanian A.V., Bakris G.L., Black H.R., Cushman W.C., Green L.A., Izzo J.L., Jones D.W., Materson B.J., Oparil S., and Wright Jr. J.T. The seventh report of the joint national committee on prevention detection, evaluation, and treatment of high blood pressure, The JNC 7 Report. J Am Med Assoc 289 19 (2003) 2560-2572
6. Fowler B, Jamrozik K, Norman P, Allen Y. Prevalence of peripheral arterial disease: persistence of excess risk in former smokers. Aust N Z J Public Health 2002;26(3):219-24.
7. Bhatt D., Steg P., Ohman E., Hirsch A., Ikeda Y., Mas J., Goto S., Liau C.-S., Richard A.J., Röther J., Wilson P.W.F., and for the REACH Registry Investigators. International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. J Am Med Assoc 295 2 (2006) 180-189
8. Ohman E., Bhatt D., Wilson P., Rother J., Steg P., and for REACH Registry Investigators. The REACH Registry: an international, prospective, observational investigation in subjects at risk of atherothrombotic events-study design. Am Heart J 151 4 (2006) 786
9. National Heart Foundation of Australia. Heart Foundation Guide to Management of Hypertension for Doctors. National Heart Foundation; 2004. p. 1-15.
10. National Heart Foundation of Australia & Cardiac Society of, Australia and New Zealand. Reducing Risk in Heart Disease: Guidelines for preventing cardiovascular events in people with coronary heart disease: National Heart Foundation of Australia; 2003.
11. Fulcher G.R., Amarena J.V., Conner G.W., Gilbert R.E., and Hankey G.J. Practical Implementation Taskforce for the Prevention of Cardiovascular Disease. Prevention of cardiovascular disease: an evidence-based clinical aid 2004. Med J Aust 181 6 Suppl. (2004) F4-F14
12. Wright D.J., Grayson A.D., and Jackson M.C.D. The reality of treating dyslipidaemia in patients with coronary heart disease: a primary care survey. Int J Clin Pract 57 6 (2003) 488-491
13. Ashenden R., Silagy C., and Weller D. A systematic review of the effectiveness of promoting lifestyle change in general practice. Fam Pract 14 2 (1997) 160-174
14. Ioannides-Demos L.L., Proietto J., Tonkin A.M., and McNeil J.J. Safety of drug therapies used for weight loss and treatment of obesity. Drug Safe 29 4 (2006) 277-302
15. National Primary Care Collaborative. National Level Results - March 2006; 2006.